Sanofi appoints Ameet Nathwani Chief Digital Officer
12 Febrero 2019 - 12:02AM
|
Press
Release Source: Sanofi (EURONEXT: SAN) (NASDAQ: SNY)
|
Sanofi appoints Ameet Nathwani Chief Digital Officer
- Ameet Nathwani, M.D., will also continue to serve as Executive
Vice-President, Chief Medical Officer
Paris - February 12, 2019 - Sanofi has
appointed Ameet Nathwani, M.D. as Chief Digital Officer in addition
to his current role of Executive Vice President, Chief Medical
Officer.
As Chief Digital Officer, Dr. Nathwani will be
responsible for enhancing Sanofi's strategy to integrate digital
technologies and medical science to ultimately improve patient
outcomes. His mandate will include scaling up Sanofi's ongoing
portfolio of digital initiatives by developing broad external
partnerships, building out internal infrastructures, and exploring
new business opportunities for Sanofi in the digital space. "Over
the last two years, we have made fast progress in creating an
innovative portfolio of digital initiatives and novel
partnerships," said Olivier Brandicourt, Chief Executive Officer at
Sanofi. "With Ameet's wide experience in digital health and
analytics, we will be able to further advance our capabilities to
re-invent not only the way we discover and develop medicines but
the types of future products we may offer to patients around the
world." Dr. Nathwani joined Sanofi in May 2016 as Chief Medical
Officer.
A U.K. citizen, born in Uganda and educated in
the U.K., Dr. Nathwani has more than 20 years of experience in the
pharmaceutical industry. Prior to joining Sanofi, Dr. Nathwani was
the Global Head of Medical Affairs, Novartis Pharma AG and served
as an extended member of the Pharma Executive Committee where he
led the establishment of a Real World Evidence Center of Excellence
and Digital Medicine capability.
He joined Novartis in 2004 as the Senior Vice
President and Global Development Head of the Cardiovascular and
Metabolic Franchise and over the period of 11 years held a number
of senior development and commercial positions including the Global
Head of the Critical Care Business Franchise. Dr. Nathwani began
his pharmaceutical career in 1994 when he joined Glaxo Group
Research. From 1994 to 2004, he held increasingly senior global
functional and franchise leadership roles in research and
development in Glaxo, SmithKline Beecham and GlaxoSmithKline, both
in Europe and the U.S.
Dr. Nathwani qualified in medicine in 1987 in
London, acquired his specialization in Cardiology at a number of
University Hospitals in London, and has a diploma in Pharmaceutical
Medicine and an executive Master's Degree in Business
Administration.
About Sanofi Sanofi is dedicated to supporting
people through their health challenges. We are a global
biopharmaceutical company focused on human health. We prevent
illness with vaccines, provide innovative treatments to fight pain
and ease suffering. We stand by the few who suffer from rare
diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is
transforming scientific innovation into healthcare solutions around
the globe. Sanofi, Empowering Life |
Media Relations Contact Quentin Vivant Tel.: +33 (0)1 53 77
46 46 mr@sanofi.com |
Investor Relations
Contact George Grofik Tel.: +33 (0)1 53 77 45 45
ir@sanofi.com |
|
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024